---
case_id: astrazeneca-optimized-clinical-trial-design
organisation: AstraZeneca
title: Optimized Clinical Trial Design
date_created: '2026-01-29'
date_updated: '2026-01-29'
sources:
- id: S1
  title: https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-launche...
  url: https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-launches-evinova-health-tech-business-to-accelerate-innovation-across-the-life-sciences-sector.html
  raw_file: ''
  text_file: sources/text/S1.txt
  extraction_method: unknown
  extraction_quality: high
  is_multi_page: false
  related_urls: []
- id: S2
  title: https://www.artificialintelligence-news.com/news/astrazeneca-ai-clinical-trials-...
  url: https://www.artificialintelligence-news.com/news/astrazeneca-ai-clinical-trials-2025/
  raw_file: ''
  text_file: sources/text/S2.txt
  extraction_method: unknown
  extraction_quality: high
  is_multi_page: false
  related_urls: []
- id: S3
  title: https://www.onestudyteam.com/blog/astrazeneca-breast-cancer-clinical-trial-enrol...
  url: https://www.onestudyteam.com/blog/astrazeneca-breast-cancer-clinical-trial-enrollment
  raw_file: ''
  text_file: sources/text/S3.txt
  extraction_method: trafilatura
  extraction_quality: high
  is_multi_page: false
  related_urls: []
- id: S4
  title: https://www.zenml.io/llmops-database/multi-agent-ai-development-assistant-for-cl...
  url: https://www.zenml.io/llmops-database/multi-agent-ai-development-assistant-for-clinical-trial-data-analysis
  raw_file: ''
  text_file: sources/text/S4.txt
  extraction_method: trafilatura
  extraction_quality: high
  is_multi_page: false
  related_urls: []
- id: S5
  title: https://www.klover.ai/astrazeneca-ai-strategy-analysis-of-ai-dominance-in-pharma...
  url: https://www.klover.ai/astrazeneca-ai-strategy-analysis-of-ai-dominance-in-pharmaceutical-biotech/
  raw_file: ''
  text_file: sources/text/S5.txt
  extraction_method: unknown
  extraction_quality: high
  is_multi_page: false
  related_urls: []
value_claims:
- id: VC-001
  claim_title: Sites using StudyTeam randomize more patients per site per month
  claim_description: Research sites using Reify Health's StudyTeam platform with AstraZeneca
    achieved higher patient randomization rates per site per month compared to sites
    not using the platform.
  source_ids:
  - S3
  source_quote: Sites using StudyTeam with AstraZeneca randomize more patients per
    site per month and provide overwhelmingly positive feedback
  quote_location: Body paragraph 3
  ai_attribution: contributing
  attribution_evidence: StudyTeam platform uses AI-powered Smart Patient Discovery
    feature to suggest potential patients, contributing to improved randomization
    rates alongside workflow improvements
  verification_status: verified
  evidence_level: method
  evidence_grade: secondary_high
  application_type: capability_enhancement
  mechanism:
  - optimization
  - augmentation
  outcome:
  - velocity
  cognitive_depth: predictive
  metric_raw: null
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-002
  claim_title: 100% site retention rate for StudyTeam in subsequent studies
  claim_description: All research sites that used StudyTeam platform in AstraZeneca
    trials chose to continue using it for subsequent studies, indicating high satisfaction
    and perceived value.
  source_ids:
  - S3
  source_quote: 100% of sites using StudyTeam in its trials choose to do so for subsequent
    studies
  quote_location: Body paragraph 3
  ai_attribution: contributing
  attribution_evidence: The platform includes AI-powered Smart Patient Discovery feature
    that contributes to site satisfaction alongside other workflow features
  verification_status: verified
  evidence_level: adoption
  evidence_grade: primary
  application_type: capability_enhancement
  mechanism:
  - optimization
  - augmentation
  outcome:
  - experience
  cognitive_depth: predictive
  metric_raw:
    value: '100'
    currency: null
    magnitude: null
    timeframe: null
    metric_type: percentage
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-003
  claim_title: Accelerated enrollment timelines through improved patient matching
  claim_description: StudyTeam's Smart Patient Discovery feature enables sites to
    more effectively connect patients to trials, reducing site burden and accelerating
    enrollment timelines.
  source_ids:
  - S3
  source_quote: our technology enables AstraZeneca to overcome the traditional challenges
    of moving candidates effectively through the enrollment funnel...ultimately accelerate
    enrollment timelines
  quote_location: Quote from Ralph Passarella, CEO
  ai_attribution: direct
  attribution_evidence: Smart Patient Discovery feature uses protocol information
    to algorithmically suggest potential patients to research site coordinators, directly
    enabling faster patient matching
  verification_status: needs_review
  evidence_level: method
  evidence_grade: secondary_high
  application_type: capability_enhancement
  mechanism:
  - optimization
  - automation
  outcome:
  - velocity
  cognitive_depth: predictive
  metric_raw: null
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-004
  claim_title: Development Assistant deployed from concept to production MVP in six
    months
  claim_description: AstraZeneca's AI-powered Development Assistant for clinical trial
    data analysis went from concept to production MVP in approximately six months,
    faster than typical AI initiatives at the company.
  source_ids:
  - S4
  source_quote: The project achieved concept to production MVP in approximately six
    months, which the speaker noted was faster than typical AI initiatives at the
    company
  quote_location: Timeline and Results section
  ai_attribution: direct
  attribution_evidence: The Development Assistant is an AI agent using LLMs and multi-agent
    architecture to enable natural language querying of clinical trial data, directly
    responsible for the capability
  verification_status: verified
  evidence_level: outcome
  evidence_grade: primary
  application_type: capability_creation
  mechanism:
  - innovation
  outcome:
  - velocity
  cognitive_depth: autonomous
  metric_raw:
    value: '6'
    currency: null
    magnitude: null
    timeframe: null
    metric_type: absolute_value
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-005
  claim_title: Natural language querying of clinical trial data with visualization
  claim_description: Development Assistant enables researchers to query clinical trial
    data using natural language, automatically generating SQL queries, retrieving
    data, and creating visualizations without technical expertise.
  source_ids:
  - S4
  source_quote: 'a data scientist asking ''What are the top five countries with the
    most clinical trial sites? Visualize this in a pie chart.'' The system could:
    Accept natural language queries...Generate visualizations'
  quote_location: Initial Single-Agent Architecture section
  ai_attribution: direct
  attribution_evidence: The AI agent directly converts natural language to SQL queries
    and generates visualizations, enabling non-technical users to access insights
    previously requiring SQL expertise
  verification_status: needs_review
  evidence_level: method
  evidence_grade: primary
  application_type: capability_creation
  mechanism:
  - augmentation
  - automation
  outcome:
  - experience
  - velocity
  cognitive_depth: generative
  metric_raw: null
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-006
  claim_title: Multi-agent architecture enables cross-domain clinical insights
  claim_description: Evolution to multi-agent architecture using Amazon Bedrock enabled
    Development Assistant to handle queries across clinical, regulatory, quality,
    and other R&D domains with improved accuracy and reduced hallucinations.
  source_ids:
  - S4
  source_quote: Hallucinations increased and response accuracy decreased with larger
    data scope...The solution was migrating to Amazon Bedrock's multi-agent architecture...can
    now provide not just data retrieval but also insights, recommendations
  quote_location: Evolution to Multi-Agent Architecture section
  ai_attribution: direct
  attribution_evidence: Multi-agent AI architecture with supervisor and specialized
    domain agents directly enables accurate cross-domain querying and insight generation
    that was not possible with single-agent approach
  verification_status: needs_review
  evidence_level: method
  evidence_grade: primary
  application_type: capability_enhancement
  mechanism:
  - optimization
  - innovation
  outcome:
  - experience
  - velocity
  cognitive_depth: autonomous
  metric_raw: null
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: VC-007
  claim_title: Improved prescreening efficiency for clinical trial enrollment
  claim_description: Research sites using StudyTeam reported being more efficient
    with prescreening patients for clinical trials, enabling better tracking across
    solid tumor and hematologic malignancy trials.
  source_ids:
  - S3
  source_quote: we're now able to be even more efficient with our prescreening, thanks
    to StudyTeam. We're grateful for sponsors like AstraZeneca that focus on providing
    sites like ours the solutions we need to enroll effectively
  quote_location: Quote from Katherine Wall, Redlands Hematology Oncology
  ai_attribution: contributing
  attribution_evidence: StudyTeam's AI-powered Smart Patient Discovery contributes
    to prescreening efficiency by suggesting potential patients, working alongside
    workflow management features
  verification_status: verified
  evidence_level: method
  evidence_grade: secondary_high
  application_type: capability_enhancement
  mechanism:
  - optimization
  - augmentation
  outcome:
  - velocity
  - experience
  cognitive_depth: predictive
  metric_raw: null
  metric_classification: null
  ontology_version: '1.0'
  ontology_confidence: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
context_claims:
- id: CC-001
  context_type: organisational
  claim_title: AstraZeneca is a leading global biopharmaceutical company
  claim_description: AstraZeneca operates as a global biopharmaceutical company focused
    on drug development and clinical research
  source_ids:
  - S3
  source_quote: 'AstraZeneca (LSE/STO/Nasdaq: AZN), a leading global biopharmaceutical
    company'
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-002
  context_type: sectoral
  claim_title: Pharmaceutical and biotechnology sector
  claim_description: AstraZeneca operates in the pharmaceutical and biotechnology
    industry, specifically in drug development and clinical trials
  source_ids:
  - S3
  - S4
  source_quote: AstraZeneca, a global biopharmaceutical company
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-003
  context_type: functional
  claim_title: Clinical trial patient recruitment and enrollment
  claim_description: AstraZeneca conducts clinical trial patient recruitment and enrollment
    activities across global research sites for oncology and breast cancer studies
  source_ids:
  - S3
  source_quote: AstraZeneca will use Reify Health's StudyTeam platform to accelerate
    clinical development, alleviate burden on research sites, and improve patient
    matching for global clinical trial enrollment
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: '10397'
  apqc_name: Develop and Manage Products and Services
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-004
  context_type: scale
  claim_title: Global clinical trial operations across 100+ countries
  claim_description: AstraZeneca and other biopharma companies using StudyTeam work
    with more than 3,000 research sites in more than 100 countries
  source_ids:
  - S3
  source_quote: AstraZeneca and other top-20 global biopharma companies...use Reify
    Health's StudyTeam to work with more than 3,000 research sites in more than 100
    countries
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-005
  context_type: temporal
  claim_title: StudyTeam deployment since 2019
  claim_description: AstraZeneca has been deploying Reify Health's StudyTeam platform
    across multiple large global oncology clinical trials since 2019
  source_ids:
  - S3
  source_quote: Since 2019, AstraZeneca has deployed Reify Health's StudyTeam across
    multiple large global oncology clinical trials
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-006
  context_type: temporal
  claim_title: StudyTeam breast cancer expansion announced April 2021
  claim_description: AstraZeneca announced expansion of StudyTeam platform to breast
    cancer clinical trial portfolio in April 2021
  source_ids:
  - S3
  source_quote: BOSTON, April 20, 2021 – Reify Health announced today that AstraZeneca...has
    selected StudyTeam...to accelerate clinical development across its breast cancer
    investigational therapy portfolio
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-007
  context_type: strategic_intent
  claim_title: Goal to deliver 20 new medicines by 2030
  claim_description: AstraZeneca has a corporate goal to deliver 20 new medicines
    by 2030, driving their AI initiatives for accelerating drug development
  source_ids:
  - S4
  source_quote: AstraZeneca...embarked on an ambitious initiative to leverage AI for
    accelerating drug development as part of their broader corporate goal to deliver
    20 new medicines by 2030
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-008
  context_type: functional
  claim_title: R&D data platform and analytics infrastructure
  claim_description: AstraZeneca operates a Drug Development Data Platform (3DP) with
    thousands of users, serving as foundation for AI initiatives across clinical,
    regulatory, safety, and quality domains
  source_ids:
  - S4
  source_quote: 'Rather than building from scratch, AstraZeneca strategically chose
    to build their AI solution on top of an existing platform called 3DP (Drug Development
    Data Platform). This decision was driven by several factors: The platform already
    had thousands of users'
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: '10101'
  apqc_name: Develop Vision and Strategy
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-009
  context_type: temporal
  claim_title: Development Assistant production deployment in 2025
  claim_description: The Development Assistant AI tool is in production as of 2025
    and actively being expanded to additional domains
  source_ids:
  - S4
  source_quote: The tool is now in production and actively being expanded to additional
    domains in 2025
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-010
  context_type: organisational
  claim_title: Heavily regulated pharmaceutical environment
  claim_description: AstraZeneca operates in a heavily regulated pharmaceutical environment
    where data quality, accuracy, governance, and patient safety are paramount considerations
  source_ids:
  - S4
  source_quote: The initiative represents an interesting example of LLMOps in a heavily
    regulated pharmaceutical environment, where data quality, accuracy, and governance
    are paramount
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-011
  context_type: products_services
  claim_title: Breast cancer investigational therapy portfolio
  claim_description: AstraZeneca maintains an extensive breast cancer clinical trial
    pipeline with investigational therapies under development
  source_ids:
  - S3
  source_quote: AstraZeneca...has selected StudyTeam...to accelerate clinical development
    across its breast cancer investigational therapy portfolio
  verification_status: unverified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
- id: CC-012
  context_type: products_services
  claim_title: Global oncology clinical trials program
  claim_description: AstraZeneca conducts multiple large global oncology clinical
    trials across various cancer types including breast cancer, solid tumors, and
    hematologic malignancies
  source_ids:
  - S3
  source_quote: Since 2019, AstraZeneca has deployed Reify Health's StudyTeam across
    multiple large global oncology clinical trials
  verification_status: verified
  verification_confidence: high
  inferred_from: null
  apqc_code: null
  apqc_name: null
  human_validation:
    reviewed: false
    reviewer_verdict: null
    attribution_correct: null
    attribution_override: null
    missed_claim: false
    review_notes: null
    review_date: null
    reviewer_id: null
verification_summary:
  value_claims:
    total: 7
    verified: 4
    needs_review: 3
    rejected: 0
    by_attribution:
      contributing: 3
      direct: 4
  context_claims:
    total: 12
    verified: 6
    unverified: 6
    inferred: 0
  all_value_verified: false
  all_context_verified: false
human_validation_summary: null
status: needs_review
confidence: high
review_flags: []
ontology_metadata:
  version_used: '1.0'
  tagged_date: '2026-01-29'
  needs_retagging: false
---

# Optimized Clinical Trial Design

## Executive Summary

AstraZeneca: Sites using StudyTeam randomize more patients per site per month.

## Key Findings

- **Sites using StudyTeam randomize more patients per site per month** — verified (method)
  - Quote: "Sites using StudyTeam with AstraZeneca randomize more patients per site per month and provide overwhelmingly positive feedback"

- **100% site retention rate for StudyTeam in subsequent studies** — verified (adoption)
  - Quote: "100% of sites using StudyTeam in its trials choose to do so for subsequent studies"

- **Accelerated enrollment timelines through improved patient matching** — needs_review (method)
  - Quote: "our technology enables AstraZeneca to overcome the traditional challenges of moving candidates effectively through the enrollment funnel...ultimately accelerate enrollment timelines"

- **Development Assistant deployed from concept to production MVP in six months** — verified (outcome)
  - Quote: "The project achieved concept to production MVP in approximately six months, which the speaker noted was faster than typical AI initiatives at the company"

- **Natural language querying of clinical trial data with visualization** — needs_review (method)
  - Quote: "a data scientist asking 'What are the top five countries with the most clinical trial sites? Visualize this in a pie chart.' The system could: Accept natural language queries...Generate visualizations"

- **Multi-agent architecture enables cross-domain clinical insights** — needs_review (method)
  - Quote: "Hallucinations increased and response accuracy decreased with larger data scope...The solution was migrating to Amazon Bedrock's multi-agent architecture...can now provide not just data retrieval but ..."

- **Improved prescreening efficiency for clinical trial enrollment** — verified (method)
  - Quote: "we're now able to be even more efficient with our prescreening, thanks to StudyTeam. We're grateful for sponsors like AstraZeneca that focus on providing sites like ours the solutions we need to enrol..."

## Sources

- **S1**: https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-launches-evinova-health-tech-business-to-accelerate-innovation-across-the-life-sciences-sector.html
- **S2**: https://www.artificialintelligence-news.com/news/astrazeneca-ai-clinical-trials-2025/
- **S3**: https://www.onestudyteam.com/blog/astrazeneca-breast-cancer-clinical-trial-enrollment
- **S4**: https://www.zenml.io/llmops-database/multi-agent-ai-development-assistant-for-clinical-trial-data-analysis
- **S5**: https://www.klover.ai/astrazeneca-ai-strategy-analysis-of-ai-dominance-in-pharmaceutical-biotech/
